1. The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1
2. Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses
3. Department of Health and Human Services Food and Drug Administration. Application of nucleic acid testing to blood borne pathogens and emerging technologies. OBRR/CBER/FDA workshop; 2001 Dec 4‐5; Bethesda MD. Transcript available at: URL:http://www.fda.gov/cber/minutes/workshop‐min.htm.
4. Busch MP. Closing the windows on viral transmission by blood transfusion. In: Stramer SL editor. Blood safety in the new millennium. Bethesda MD: American Association of Blood Banks; 2001:33‐54.
5. Blood Products Advisory Committee. 69th meeting: open session. FDA advisory committee meeting; 2001 Jun 14‐15; Gaithersburg MD. Transcript available at: URL:http://www.fda.gov/ohrms/dockets/ac/acmenu.htm.